The receipt of this permission paves way for the launch of Olaparib film coated tablets in India
Decision on EU marketing authorisation expected for momelotinib by early 2024
The countrywide initiative aims to spread awareness, educate the public & ensure that no one is left behind in the fight against respiratory diseases
Extraintestinal pathogenic E. coli (ExPEC) has been identified as the leading bacterial cause of sepsis
EBITDA for Q2 FY24 at Rs. 71.2 crore as compared to Rs. 79.9 crore QoQ
Dr. Reddy’s maintains that the allegations against it lack merit and will vigorously defend the litigation
PhytoSquene now available for clinical and commercial use
Lack of technology transfer stands out as a formidable barrier
NATCO's Pharmacovigilance Department was inspected from October 30, 2023 to November 1, 2023
Subscribe To Our Newsletter & Stay Updated